Department of Physiotherapy, Princess Alexandra Hospital, Metro South Health, Brisbane, Qld, Australia; Physiotherapy, School of Health & Rehabilitation Sciences, The University of Queensland, Brisbane, Qld, Australia.
The School of Allied Health Sciences and Menzies Health Institute, Griffith University, Brisbane, Qld, Australia; Allied Health Research Collaborative, Metro North Hospital and Health Service, The Prince Charles Hospital, Brisbane, Qld, Australia.
Heart Lung Circ. 2019 Dec;28(12):1795-1803. doi: 10.1016/j.hlc.2018.11.010. Epub 2018 Dec 2.
Whilst home-based telerehabilitation has been shown non-inferior to traditional centre-based rehabilitation in patients with chronic heart failure, its economic sustainability remains unknown. This study aimed to investigate the cost-utility of a home-based telerehabilitation program.
A comparative, trial-based, incremental cost-utility analysis was conducted from a health care provider's perspective. We collected data as part of a multi-centre, two-arm, non-inferiority, randomised controlled trial with 6 months follow-up. There were 53 participants randomised to either a telerehabilitation program (consisting of 12 weeks of group-based exercise and education delivered into the home via online videoconferencing) or a traditional centre-based program. Health care costs (including personnel, equipment and hospital readmissions due to heart failure) were extracted from health system records, and calculated in Australian dollars using 2013 as the base year. Health utilities were measured using the EuroQol five-dimensional (EQ-5D) questionnaire. Estimates were presented as means and 95% confidence intervals (CIs) based on bootstrapping. Costs and utility differences were plotted on a cost-effectiveness plane.
Total health care costs per participant were significantly lower in the telerehabilitation group (-$1,590, 95% CI: -2,822, -359) during the 6 months. No significant differences in quality-adjusted life years (0, 95% CI: -0.06, 0.05) were seen between the two groups.
Heart failure telerehabilitation appears to be less costly and as effective for the health care provider as traditional centre-based rehabilitation.
虽然基于家庭的远程康复在慢性心力衰竭患者中已被证明不劣于传统的基于中心的康复,但它的经济可持续性仍不清楚。本研究旨在探讨基于家庭的远程康复计划的成本效益。
从医疗保健提供者的角度进行了比较性、基于试验的增量成本效用分析。我们在一项多中心、两臂、非劣效性、随机对照试验中收集了数据,该试验有 6 个月的随访。共有 53 名参与者被随机分配到远程康复组(包括 12 周的小组锻炼和家庭在线视频会议进行的教育)或传统的中心为基础的组。医疗保健成本(包括人员、设备和因心力衰竭再次住院)从医疗系统记录中提取,并使用 2013 年作为基准年以澳元计算。健康效用使用欧洲五维健康量表(EQ-5D)问卷进行测量。使用 bootstrap 方法计算基于 bootstrapping 的平均值和 95%置信区间(CI)。成本和效用差异在成本效果平面上进行绘制。
在 6 个月期间,远程康复组的每位参与者的总医疗保健成本显著降低(-1590 澳元,95%CI:-2822,-359)。两组之间的健康调整生命年(0,95%CI:-0.06,0.05)没有显著差异。
心力衰竭远程康复对于医疗保健提供者来说似乎比传统的中心为基础的康复更具成本效益。